Page 194 - B2B Connect

Low oil prices to boost margins: Huntsman

The company is expected to benefit over the long term as many of its raw materials are derived from the oil refining process

Global catalyst market to exceed $20 bn in 2018

Efforts by developing countries such as China, India, and Russia to battle air pollution by reducing fuel sulfur levels will stimulate demand for hydrotreating catalysts, reports Freedonia Group

BioAmber appoints Francois Laurin as CFO

He replaces Andrew Ashworth, who retired as CFO on December 31, 2014

Solvay completes acquisition of Chevron Phillips' Ryton PPS biz

This will enlarge Solvay's specialty polymers offering

Pluss Polymers organises e-waste management programme

The aim of the event, organised at Mount Abu School, New Delhi, was to encourage students to participate in a collective drive to deal with e-waste

Haldia Petrochemicals may restart operations at plant

This follows the decision of lenders to infuse funds in the company after The Chatterjee Group, one of the principal promoters of HPL, agreed to invest Rs 100 crore

Biocompatible materials market in US to touch $5.6 bn

Demand for synthetic biocompatible polymers is expected to increase 4.7 percent annually to $3.2 billion in 2018, representing more than 1.4 billion pounds, says Freedonia Group in a new study

CMI Ltd bags BPCL order to supply cables

Order was placed for Kochi refinery

Bemco Hydraulics to foray into high-pressure pumps & valves business

The company is forming a JV with Jagdish Joshi, who holds the expertise in the field, for the foray

Jubilant Pharma appoints GP Singh as CEO

Prior to Jubilant, Singh had served as president of Sun Pharmaceuticals, USA

Lupin launches hypertension drug in US

The company's valsartan tablet is the AB rated generic equivalent of Novartis' Diovan tablet, which had annual US sales of $2.08 bn

Suven Life receives patents in Eurasia, Japan and Mexico

The company was granted product patents for its new chemical entities, which are used to treat disorders associated with neurodegenerative diseases

Novartis completes divestment of animal health biz to Eli Lilly

The $ 5.4-bn deal was announced by the company in April 2014

Lupin receives USFDA approval for HIV drug

The US drug regulator has given its nod for Lupin's darunavir ethanolate tablets, which are the generic versions of Janssen's Prezista tablets

Glenmark Pharma plans to out-license molecule for pain management

The molecule, which has market potential worth $1 billion, has successfully completed phase-II trials on 138 patients in Europe and India

Kabra Drugs to expand facility; target exports market

The company is planning to expand its product range and has started production of herbal products

Amgen ties up with Kite Pharma for cancer drug research

The alliance combines Amgen's oncology targets and Kite's leading CAR T cell therapy platform to develop new therapeutic candidates

Apollo Health acquires Nova Specialty Hospital

The deal, which is expected to be in the range of Rs 135-145 crores, fits into the growth strategy of AHLL providing it a larger footprint, including in some markets where it has no presence currently

Jubilant receives USFDA nod for immunosuppressant & migraine drugs

The company has received ANDA approval for mycophenolate mofetil and rizatriptan

SRF acquires DuPont's global pharma grade HFC 134a refrigerant biz

Indian firm will own DuPont's Dymel brand and will also receive the technology and know-how for setting up its own current cGMP facility for manufacturing HFC 134a pharma grade